Multiplex Real-Time PCR Assay for Detection and Classification of Klebsiella pneumoniae Carbapenemase Gene ( bla KPC ) Variants
- 1 February 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (2), 579-585
- https://doi.org/10.1128/jcm.01588-10
Abstract
Carbapenem resistance mediated by plasmid-borne Klebsiella pneumoniae carbapenemases (KPC) is an emerging problem of significant clinical importance in Gram-negative bacteria. Multiple KPC gene variants ( bla KPC ) have been reported, with KPC-2 ( bla KPC-2 ) and KPC-3 ( bla KPC-3 ) associated with epidemic outbreaks in New York City and various international settings. Here, we describe the development of a multiplex real-time PCR assay using molecular beacons (MB-PCR) for rapid and accurate identification of bla KPC variants. The assay consists of six molecular beacons and two oligonucleotide primer pairs, allowing for detection and classification of all currently described bla KPC variants ( bla KPC-2 to bla KPC-11 ). The MB-PCR detection limit was 5 to 40 DNA copies per reaction and 4 CFU per reaction using laboratory-prepared samples. The MB-PCR probes were highly specific for each bla KPC variant, and cross-reactivity was not observed using DNA isolated from several bacterial species. A total of 457 clinical Gram-negative isolates were successfully characterized by our MB-PCR assay, with bla KPC-3 and bla KPC-2 identified as the most common types in the New York/New Jersey metropolitan region. The MB-PCR assay described herein is rapid, sensitive, and specific and should be useful for understanding the ongoing evolution of carbapenem resistance in Gram-negative bacteria. As novel bla KPC variants continue to emerge, the MB-PCR assay can be modified in response to epidemiologic developments.Keywords
This publication has 47 references indexed in Scilit:
- Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2010
- Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-LactamaseAntimicrobial Agents and Chemotherapy, 2010
- Rapid identification of blaKPC-possessing Enterobacteriaceae by PCR/electrospray ionization-mass spectrometryJournal of Antimicrobial Chemotherapy, 2010
- Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on disseminationJournal of Antimicrobial Chemotherapy, 2010
- Detection of KPC in Acinetobacter spp. in Puerto RicoAntimicrobial Agents and Chemotherapy, 2010
- Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4Antimicrobial Agents and Chemotherapy, 2009
- First Report of KPC-2-Producing Klebsiella pneumoniae Strains in BrazilAntimicrobial Agents and Chemotherapy, 2009
- Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Intensive Care Units of a Chinese HospitalAntimicrobial Agents and Chemotherapy, 2008
- Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from GreeceAntimicrobial Agents and Chemotherapy, 2008
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996